Title:
Blockchain-based Hepatobiliary Disease Data Extraction & Exchange
Abstract：
Liver and gallbladder diseases affect more than one billion people around the world, but there is still a lack of successful experience and models in terms of data standardization, integration and sharing. The goal of this document is to solve the above problems through blockchain-based data circulation standards. This standard mainly describes the format of the data circulation and the application process of hepatobiliary diseases, which standardize the data collection, processing, and exchange process of hepatobiliary disease data in the medical information system, aiming to bring a new data credible circulation innovation model for medical education, data sharing applications, and medical artificial intelligence product research and development of hepatobiliary disease big data.
Keywords:
blockchain, data exchange, credible circulation, IEEE 3806™, liver cancer
Scope:
This standard specifies the blockchain-based system architecture, interfaces, protocols, testing and verification for the application and trading of Hepatobiliary Disease data across multiple organizations and stakeholders.
Standards Committee：
Digital Finance and Economy Standards Committee
Society：
IEEE Consumer Technology Society
Supporting Project：
A smart classification system for liver cancer based on the automatic understanding of multimodal artificial intelligence in electronic medical records，Beijing Natural Science Foundation of China (Grant No. Z190024)
A database of liver cancer diseases based on the application of artificial intelligence technology, AI Medical Device Innovation Task Announcement Unit by the Ministry of Industry and Information Technology and National Medical Products Administration of the People’s Republic of China- Medical Artificial Intelligence Database Project (2021).
News：
Beijing Tsinghua Changgeng Hospital leads the official release of China’s first blockchain based international standard for liver and gallbladder
On January 26, 2024, the first blockchain-based international standard for hepatobiliary diseases, led by Beijing Tsinghua Changgung Hospital affiliated with Tsinghua University, was officially released. The standard was jointly drafted by Tsinghua University’s Shenzhen International Graduate School, the Advanced Research Institute of Tsinghua University, Huacong Qingjiao Information Technology Co., Ltd., Fuzhou Data Technology Research Institute Co., Ltd., and Peking Union Medical College Hospital. The IEEE international standard titled “Blockchain-based Data Extraction and Exchange Standards for Hepatobiliary Diseases” has been formally implemented, becoming China’s first international standard specification for the application of hepatobiliary disease data based on blockchain technology. Under the leadership of Dong Jiahong, an academician of the Chinese Academy of Engineering and president of Beijing Tsinghua Changgung Hospital, the standard was co-authored by experts including Feng Xiaobin, the deputy director of the Hepatopancreatobiliary Surgery Department of the hospital, and Li Chengquan and Yang Bin from the Precision Medicine Research Institute of Tsinghua University.
According to Feng Xiaobin, the purpose of the standard is to contribute Chinese wisdom to the world, providing high-quality standards for global disease diagnosis, treatment, and scientific research, thereby forming a series of specialized data extraction and exchange standard systems. Based on the research foundation of the national hepatobiliary disease data group standard and integrating the traceable and imtamable core technology guarantee of blockchain technology, the standard is formulated for various application stages of hepatobiliary diseases, including prevention, screening, diagnosis, treatment, rehabilitation, and prognosis. It aims to establish a service standard reference for medical institutions, research institutions, and medical enterprises to facilitate the circulation of specialized hepatobiliary disease data, to create a demonstration of a trustworthy medical data circulation system with Chinese characteristics, and to extend it to international data extraction and application standards. This will bring new innovative models to medical education, data sharing applications, and the development of medical artificial intelligence products for big data on hepatobiliary diseases.
It is reported that the national hepatobiliary disease standard database, led by Beijing Tsinghua Changgung Hospital, is China’s first systematic disease standardization database project. Launched in December 2019, it has been implemented in 15 hospitals, including Beijing Tsinghua Changgung Hospital and Zhuhai People’s Hospital, and has formed a secure data sharing mechanism through blockchain technology. In 2023, five specialized databases for liver cancer, cholangiocarcinoma, hepatic echinococcosis, liver transplantation, and Yttrium-90 included a total of 17,000 cases. These databases supported the data set construction for projects such as Ministry of Industry and Information Technology and National Medical Products Administration of the People’s Republic of China’s artificial intelligence medical device innovation task, and the Beijing Natural Science Foundation projects, resulting in the publication of multiple high-level papers, the release of three group standards, and the granting of two invention patents, with nine more applied for.
The formulation and implementation of this standard are key to the trustworthy circulation of big data on hepatobiliary diseases and will become the infrastructure for international digital innovation research in hepatology. It will support the demonstration of innovative applications of national health and medical big data and stimulate the transformation of data-intensive research and development value in the industry and market. In the future, Beijing Tsinghua Changgung Hospital will continue to establish multi-center alliance unit big data infrastructure, promote the construction of national innovation application demonstration platforms, and advance the interconnection and circulation of health and medical big data.